The Effect of Dose Titration and Dose Tapering on the Tolerability of DVS SR in Women With Vasomotor Symptoms Associated With Menopause: The PRIMMUS (PRIstiq for Managing Menopause and Understanding Symptoms) Study.
Phase of Trial: Phase III
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Menopausal syndrome
- Focus Adverse reactions
- Acronyms PRIMMUS
- 09 May 2011 New trial record
- 04 May 2011 Results presented at the 59th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.